Repligen | Resultado Líquido



Net Income Alterar Data
Agilent USD 318M 33M 2025-01
Align Technology USD 103.81M 12.16M 2024-12
Bio Techne USD 34.89M 1.29M 2024-12
BioMarin Pharmaceutical USD 124.94M 18.86M 2024-12
Bristol-Myers Squibb USD 72M 1.14B 2024-12
Bruker USD 13.7M 27.2M 2024-12
Charles River Laboratories USD -215699000 284.38M 2024-12
Danaher USD 1.09B 268M 2024-12
Dentsply International USD -430000000 64M 2024-12
Exact Sciences USD -864585000 826.35M 2024-12
General Electric USD 1.9B 47M 2024-12
Henry Schein USD 94M 5M 2024-12
Illumina USD 187M 518M 2024-12
IQVIA Holdings USD 437M 152M 2024-12
Mettler Toledo International USD 252.3M 40.78M 2024-12
Myriad Genetics USD -42500000 20.4M 2024-12
Patterson Companies USD 31.26M 4.49M 2025-01
Pfizer USD 410M 4.06B 2024-12
Repligen USD -653000 3.97M 2024-09
Revvity USD 94.64M 278K 2024-12
Standard Biotools USD -34072000 7.13M 2024-12
Thermo Fisher Scientific USD 1.83B 201M 2024-12
Waters USD 231.4M 69.9M 2024-12
West Pharmaceutical Services USD 130.1M 5.9M 2024-12



Repligen Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.